<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.crescendobiologics.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/</loc>
		<lastmod>2023-08-23T12:18:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/business-weekly-crescendo-biologics-steps-up-war-against-hard-to-treat-cancers/</loc>
		<lastmod>2021-06-22T16:58:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/pmlive-a-snapshot-of-crescendo-biologics/</loc>
		<lastmod>2021-06-22T17:00:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/crescendo-ceo-says-takedas-decision-to-exercise-licence-option-is-validation-of-its-immunotherapy-platform/</loc>
		<lastmod>2021-06-22T17:01:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/crescendo-team-featured-in-cambridge-tv-video/</loc>
		<lastmod>2021-06-22T17:03:25+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/crescendos-psoriasis-cancer-collaborations/</loc>
		<lastmod>2021-11-24T09:44:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/media-coverage-crescendo-biontech-collaboration/</loc>
		<lastmod>2022-08-16T14:14:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/unlocking-the-potential-of-psma-as-a-cancer-target/</loc>
		<lastmod>2023-08-23T12:11:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/crescendo-biologics-provides-background-on-research-and-what-it-means-for-drug-discovery/</loc>
		<lastmod>2023-08-23T12:12:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/50-movers-shakers-in-biobusiness-2018/</loc>
		<lastmod>2023-08-23T12:13:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/crescendo-biologics-pioneers-a-new-approach-to-using-antibodies-in-fight-against-cancer/</loc>
		<lastmod>2023-08-23T12:14:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/ceo-peter-pack-interviewed-by-scrip-at-bio-europe-spring-2018/</loc>
		<lastmod>2023-08-23T12:14:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/building-multifunctional-biologics-to-treat-disease/</loc>
		<lastmod>2023-08-23T12:15:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/developing-differentiated-multifunctional-immuno-oncology-products/</loc>
		<lastmod>2023-08-23T12:15:40+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/ceo-peter-pack-interviewed-by-labiotech/</loc>
		<lastmod>2023-08-23T12:16:10+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/adc-special-report/</loc>
		<lastmod>2023-08-23T12:16:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.crescendobiologics.com/in-the-news/crescendo-oncology-article-nature-biopharma/</loc>
		<lastmod>2023-08-23T12:18:02+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->